NCT01802853View on ClinicalTrials.gov

A Bioavailability and Pharmacokinetic Study of Subcutaneous and Intravenous RO6811135 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Healthy Volunteer
Interventions
DRUG

RO6811135

Single subcutaneous dose

DRUG

RO6811135

Single intravenous dose

Trial Locations (1)

LS2 9LH

Leeds

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01802853 - A Bioavailability and Pharmacokinetic Study of Subcutaneous and Intravenous RO6811135 in Healthy Volunteers | Biotech Hunter | Biotech Hunter